We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.25M
1-Year Est. Return 26.51%
This Fund
S&P 500
This Quarter Est. Return
-5.65%
1 Year Est. Return
-26.51%
3 Year Est. Return
-47.48%
5 Year Est. Return
-89.34%
10 Year Est. Return
AUM
$1.25M
AUM Growth
-$233K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRX icon
1
TScan Therapeutics
TCRX
$24M
$617K 49.27%
630,000
BRNS
2
DELISTED
Barinthus Biotherapeutics
BRNS
$424K 33.82%
642,204
HOWL icon
3
Werewolf Therapeutics
HOWL
$46.8M
$212K 16.92%
589,102

Similar funds

DC Funds's Q2 2026 Portfolio in Review

As of Q2 2026, DC Funds held 3 positions worth $1.25M, down 16% from $1.49M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $1.25M portfolio in Q2 2026.
  • DC Funds opened 0 new positions and closed 0 in Q2 2026.
  • DC Funds's portfolio value fell 16% quarter-over-quarter to $1.25M.

Based on DC Funds's 13F filing for Q2 2026, filed 14 Aug 2026.